$EXAS
EXACT SCIENCES CORP Stock $exas

$exas Overview Financials Valuation SEC Filings Company Website

2012 Q4 Form 10-Q Financial Statement

#000110465912073727 Filed on November 02, 2012

Income Statement

Concept	2012 Q4	2012 Q3	2011 Q3
Revenue	$1.036M	$1.036M	$1.039M
YoY Change	-0.58%	-0.29%	-25.79%
Cost Of Revenue	$0.00	$0.00	$6.000K
YoY Change	-100.0%	-100.0%
Gross Profit	$1.036M	$1.036M	$1.033M
YoY Change	0.0%	0.29%	-26.21%
Gross Profit Margin	100.0%	100.0%	99.42%
Selling, General & Admin	$4.639M	$3.553M	$2.766M
YoY Change	40.58%	28.45%	31.71%
% of Gross Profit	447.78%	342.95%	267.76%
Research & Development	$10.44M	$10.49M	$6.110M
YoY Change	36.07%	71.7%	135.0%
% of Gross Profit	1007.63%	1012.64%	591.48%
Depreciation & Amortization	$300.0K	$300.0K	$200.0K
YoY Change	200.0%	50.0%	100.0%
% of Gross Profit	28.96%	28.96%	19.36%
Operating Expenses	$15.08M	$14.04M	$8.876M
YoY Change	37.42%	58.22%	84.92%
Operating Profit	-$14.04M	-$13.01M	-$7.843M
YoY Change	41.32%	65.85%	130.68%
Interest Expense	$20.00K	$11.00K	$5.000K
YoY Change	233.33%	120.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$14.00M	-$13.00M	-$7.800M
YoY Change	41.41%	66.67%	129.41%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$14.00M	-$13.00M	-$7.800M
YoY Change	41.41%	66.67%	129.41%
Net Earnings / Revenue	-1351.35%	-1254.83%	-750.72%
Basic Earnings Per Share
Diluted Earnings Per Share	-$220.1K	-$214.9K	-$148.9K
COMMON SHARES
Basic Shares Outstanding	63.77M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2012 Q4	2012 Q3	2011 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$108.1M	$118.6M	$75.40M
YoY Change	15.74%	57.29%	116.67%
Cash & Equivalents	$13.35M	$12.66M	$4.995M
Short-Term Investments	$94.80M	$105.9M	$70.40M
Other Short-Term Assets	$600.0K	$1.300M	$900.0K
YoY Change	-40.0%	44.44%	200.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$108.7M	$119.8M	$76.30M
YoY Change	15.17%	57.04%	116.76%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.405M	$3.629M	$2.200M
YoY Change	33.11%	64.95%	175.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$3.405M	$3.629M	$2.200M
YoY Change	33.11%	64.95%	175.0%
TOTAL ASSETS
Total Short-Term Assets	$108.7M	$119.8M	$76.30M
Total Long-Term Assets	$3.405M	$3.629M	$2.200M
Total Assets	$112.1M	$123.5M	$78.50M
YoY Change	15.64%	57.26%	118.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.652M	$1.030M	$1.000M
YoY Change	377.39%	3.0%	150.0%
Accrued Expenses	$3.327M	$4.084M	$2.300M
YoY Change	8.41%	77.57%	35.29%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$300.0K	$400.0K
YoY Change
Total Short-Term Liabilities	$11.46M	$9.612M	$7.400M
YoY Change	43.6%	29.89%	-1.33%
LONG-TERM LIABILITIES
Long-Term Debt	$1.000M	$1.000M	$1.000M
YoY Change	0.0%	0.0%	0.0%
Other Long-Term Liabilities	$400.0K	$1.400M	$5.500M
YoY Change	-91.11%	-74.55%	-42.71%
Total Long-Term Liabilities	$1.000M	$1.000M	$6.500M
YoY Change	0.0%	-84.62%	-38.68%
TOTAL LIABILITIES
Total Short-Term Liabilities	$11.46M	$9.612M	$7.400M
Total Long-Term Liabilities	$1.000M	$1.000M	$6.500M
Total Liabilities	$12.46M	$10.61M	$13.90M
YoY Change	38.74%	-23.65%	-23.63%
SHAREHOLDERS EQUITY
Retained Earnings	-$274.2M	-$260.3M
YoY Change	23.63%
Common Stock	$372.8M	$370.8M
YoY Change	22.08%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$98.60M	$110.7M	$64.60M
YoY Change
Total Liabilities & Shareholders Equity	$112.1M	$123.5M	$78.50M
YoY Change	15.64%	57.26%	118.06%

Cashflow Statement

Concept	2012 Q4	2012 Q3	2011 Q3
OPERATING ACTIVITIES
Net Income	-$14.00M	-$13.00M	-$7.800M
YoY Change	41.41%	66.67%	129.41%
Depreciation, Depletion And Amortization	$300.0K	$300.0K	$200.0K
YoY Change	200.0%	50.0%	100.0%
Cash From Operating Activities	-$10.40M	-$10.30M	-$7.200M
YoY Change	16.85%	43.06%	89.47%
INVESTING ACTIVITIES
Capital Expenditures	-$100.0K	$100.0K	-$900.0K
YoY Change	-80.0%	-111.11%	800.0%
Acquisitions
YoY Change
Other Investing Activities	$11.00M	-$41.20M	-$25.50M
YoY Change	-14.06%	61.57%	2733.33%
Cash From Investing Activities	$10.90M	-$41.10M	-$26.40M
YoY Change	-11.38%	55.68%	2540.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$57.80M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	200.0K	57.90M	400.0K
YoY Change	-99.27%	14375.0%	-71.43%
NET CHANGE
Cash From Operating Activities	-10.40M	-10.30M	-7.200M
Cash From Investing Activities	10.90M	-41.10M	-26.40M
Cash From Financing Activities	200.0K	57.90M	400.0K
Net Change In Cash	700.0K	6.500M	-33.20M
YoY Change	-97.72%	-119.58%	876.47%
FREE CASH FLOW
Cash From Operating Activities	-$10.40M	-$10.30M	-$7.200M
Capital Expenditures	-$100.0K	$100.0K	-$900.0K
Free Cash Flow	-$10.30M	-$10.40M	-$6.300M
YoY Change	22.62%	65.08%	70.27%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	us-gaap	Interest Expense InterestExpense	15000	USD
CY2011Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3069000	USD
CY2011Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	4143000	USD
CY2012Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q3	us-gaap	Liabilities Current LiabilitiesCurrent	9612000	USD
CY2011Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7977000	USD
CY2012Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1000000	USD
CY2011Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1000000	USD
CY2011Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	765000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	35781000	USD
CY2011Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	57580000	USD
CY2011Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1034000	USD
CY2012Q3	us-gaap	Assets Current AssetsCurrent	119824000	USD
CY2011Q4	us-gaap	Assets Current AssetsCurrent	94395000	USD
CY2011Q4	exas	Laboratory Equipment Gross LaboratoryEquipmentGross	2314000	USD
CY2011Q4	exas	Office And Computer Equipment Gross OfficeAndComputerEquipmentGross	729000	USD
CY2011Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	288000	USD
CY2011Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	23000	USD
CY2012Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5091000	USD
CY2011Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3354000	USD
CY2011Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	796000	USD
CY2012Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3629000	USD
CY2011Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2558000	USD
CY2012Q3	us-gaap	Assets Assets	123453000	USD
CY2011Q4	us-gaap	Assets Assets	96953000	USD
CY2011Q4	exas	Interest Payable Noncurrent InterestPayableNoncurrent	42000	USD
CY2011Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	4439000	USD
CY2011Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2011Q4	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2012Q3	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2011Q4	us-gaap	Common Stock Value CommonStockValue	566000	USD
CY2011Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	304767000	USD
CY2011Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-14000	USD
CY2011Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-221824000	USD
CY2012Q3	us-gaap	Stockholders Equity StockholdersEquity	110657000	USD
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	83495000	USD
CY2012Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	123453000	USD
CY2011Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	96953000	USD
CY2012Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2011Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
	dei	Document Period End Date DocumentPeriodEndDate	2012-09-30
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2012Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	63767680	shares
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2012
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
CY2011Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-38000	USD
CY2012Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2011Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2012Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2011Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2012Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2011Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2012Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2011Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2012Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2011Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2012Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	63753363	shares
CY2011Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	56624763	shares
CY2012Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	63753363	shares
CY2011Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	56624763	shares
CY2011Q3	us-gaap	Royalty Revenue RoyaltyRevenue	4000	USD
	us-gaap	Royalty Revenue RoyaltyRevenue	14000	USD
CY2011Q3	us-gaap	Licenses Revenue LicensesRevenue	1035000	USD
	us-gaap	Licenses Revenue LicensesRevenue	3107000	USD
CY2011Q3	us-gaap	Revenues Revenues	1039000	USD
	us-gaap	Revenues Revenues	3121000	USD
CY2011Q3	us-gaap	Cost Of Revenue CostOfRevenue	6000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	18000	USD
CY2012Q3	us-gaap	Gross Profit GrossProfit	1036000	USD
CY2011Q3	us-gaap	Gross Profit GrossProfit	1033000	USD
	us-gaap	Gross Profit GrossProfit	3108000	USD
	us-gaap	Gross Profit GrossProfit	3103000	USD
CY2011Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6110000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14296000	USD
CY2011Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1951000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5931000	USD
CY2011Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	815000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1763000	USD
CY2012Q3	us-gaap	Operating Expenses OperatingExpenses	14044000	USD
CY2011Q3	us-gaap	Operating Expenses OperatingExpenses	8876000	USD
	us-gaap	Operating Expenses OperatingExpenses	41708000	USD
	us-gaap	Operating Expenses OperatingExpenses	21990000	USD
CY2012Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-13008000	USD
CY2011Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-7843000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-38600000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-18887000	USD
CY2011Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	75000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	131000	USD
CY2011Q3	us-gaap	Interest Expense InterestExpense	5000	USD
CY2012Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-12952000	USD
CY2011Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-7773000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-38433000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-18771000	USD
CY2011Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.15
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.36
CY2011Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	52443000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	52129000	shares
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-51000	USD
CY2012Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-12913000	USD
CY2011Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-7811000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-38327000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-18822000	USD
	us-gaap	Depreciation Depreciation	262000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	2707000	USD
	us-gaap	Deferred Revenue Revenue Recognized DeferredRevenueRevenueRecognized	-3107000	USD
	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	80000	USD
	us-gaap	Restricted Stock Expense RestrictedStockExpense	1000000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	621000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-51000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	596000	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	15000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-33795000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-18640000	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	71202000	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	17128000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1599000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-49171000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-55673000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	556000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	59845000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	556000	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-23121000	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-73757000	USD
CY2010Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	78752000	USD
CY2011Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4995000	USD
	us-gaap	Available For Sale Securities Change In Net Unrealized Holding Gain Loss AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLoss	-51000	USD
	us-gaap	Deferred Compensation Arrangement With Individual Employer Contribution DeferredCompensationArrangementWithIndividualEmployerContribution	169000	USD
	us-gaap	Stock Issued During Period Value Issued For Noncash Considerations StockIssuedDuringPeriodValueIssuedForNoncashConsiderations	194000	USD
	us-gaap	Deferred Compensation Arrangement With Individual Shares Issued DeferredCompensationArrangementWithIndividualSharesIssued	27872	shares
	us-gaap	Deferred Compensation Arrangement With Individual Shares Issued DeferredCompensationArrangementWithIndividualSharesIssued	32872	shares
	us-gaap	Stock Issued During Period Shares Issued For Noncash Consideration StockIssuedDuringPeriodSharesIssuedForNoncashConsideration	34336	shares
	us-gaap	Stock Issued During Period Shares Issued For Noncash Consideration StockIssuedDuringPeriodSharesIssuedForNoncashConsideration	27110	shares
	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	4168000	USD
CY2012Q3	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	105820000	USD
CY2012Q3	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	92000	USD
	us-gaap	Description Of New Accounting Pronouncements Not Yet Adopted DescriptionOfNewAccountingPronouncementsNotYetAdopted	<table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> <p style="MARGIN: 0in 0in 0pt"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">(10) RECENT ACCOUNTING PRONOUNCEMENTS</font></b></p> <p style="MARGIN: 0in 0in 0pt; TEXT-INDENT: 0.5in"><b><i><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman" size="2"> </font></i></b></p> <p style="MARGIN: 0in 0in 0pt; TEXT-INDENT: 0.5in"><b><i><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman" size="2">Presentation of Comprehensive Income</font></i></b></p> <p style="MARGIN: 0in 0in 0pt; TEXT-INDENT: 20.15pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2"> </font></p> <p style="MARGIN: 0in 0in 0pt; TEXT-INDENT: 20.15pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">In June 2011, the FASB issued an accounting standard update which requires the presentation of components of other comprehensive income with the components of net income in either (1) a continuous statement of comprehensive income that contains two sections, net income and other comprehensive income, or (2) two separate but consecutive statements. This accounting standard update eliminates the option to present components of other comprehensive income as part of the statement of stockholders’ equity, and is effective for interim and annual periods beginning after December 15, 2011, and shall be applied retrospectively. Other than a change in presentation, the implementation of this accounting pronouncement did not have a material impact on our financial statements.</font></p> <p style="MARGIN: 0in 0in 0pt; TEXT-INDENT: 0.5in"><b><i><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman" size="2"> </font></i></b></p> <p style="MARGIN: 0in 0in 0pt; TEXT-INDENT: 0.5in"><b><i><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman" size="2">Amendments to Fair Value Measurements</font></i></b></p> <p style="MARGIN: 0in 0in 0pt; TEXT-INDENT: 20.15pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2"> </font></p> <p style="MARGIN: 0in 0in 0pt; TEXT-INDENT: 20.15pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">In May 2011, the FASB issued an accounting standard update that amends the accounting standard on fair value measurements. The accounting standard update provides for a consistent definition and measurement of fair value, as well as similar disclosure requirements between GAAP and International Financial Reporting Standards (IFRS). The accounting standard update changes fair value measurement principles, clarifies the application of existing fair value measurement, and expands the fair value disclosure requirements, particularly for Level 3 fair value measurements. The amendments in this accounting standard update are to be applied prospectively and are effective for interim and annual periods beginning after December 15, 2011. The adoption of this accounting standard update did not have a material effect on our financial statements.</font></p></td></tr></table>
	us-gaap	Use Of Estimates UseOfEstimates	<table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> <p style="MARGIN: 0in 0in 0pt"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">Use of Estimates</font></b></p> <p style="MARGIN: 0in 0in 0pt; TEXT-INDENT: 20.15pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2"> </font></p> <p style="MARGIN: 0in 0in 0pt; TEXT-INDENT: 20.15pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.</font></p></td></tr></table>
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> <p style="MARGIN: 0in 0in 0pt"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">Reclassifications</font></b></p> <p style="MARGIN: 0in 0in 0pt; TEXT-INDENT: 22.3pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2"> </font></p> <p style="MARGIN: 0in 0in 0pt; TEXT-INDENT: 22.3pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">Certain prior year amounts have been reclassified to conform to the current year presentation.</font></p></td></tr></table>
	exas	Number Of Objectives Of Entitys Investment Strategy NumberOfObjectivesOfEntitysInvestmentStrategy	2	objective
CY2011Q4	us-gaap	Available For Sale Securities Gross Unrealized Losses1 AvailableForSaleSecuritiesGrossUnrealizedLosses1	14000	USD
CY2012Q3	us-gaap	Available For Sale Securities Fair Value Disclosure AvailableForSaleSecuritiesFairValueDisclosure	105912000	USD
CY2011Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	57594000	USD
CY2011Q4	us-gaap	Available For Sale Securities Fair Value Disclosure AvailableForSaleSecuritiesFairValueDisclosure	57580000	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7625000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7507000	shares
CY2012Q3	us-gaap	Licenses Revenue LicensesRevenue	1036000	USD
	us-gaap	Licenses Revenue LicensesRevenue	3108000	USD
CY2012Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1500000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4000000	USD
CY2012Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	10700000	USD
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y6M25D
CY2012Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12660000	USD
CY2012Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	6325000	shares
CY2012Q3	us-gaap	Share Price SharePrice	9.75
CY2012Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	57755000	USD
CY2012Q3	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	3900000	USD
	exas	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Under Licensing Agreement ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsUnderLicensingAgreement	250000	shares
	exas	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Under Consulting Agreement ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsUnderConsultingAgreement	75000	shares
CY2011Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1200000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2700000	USD
CY2012Q3	us-gaap	Loans Payable Fair Value Disclosure LoansPayableFairValueDisclosure	1000000	USD
CY2011Q4	us-gaap	Loans Payable Fair Value Disclosure LoansPayableFairValueDisclosure	1000000	USD
CY2012Q3	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	105912000	USD
CY2012Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1252000	USD
CY2012Q3	exas	Laboratory Equipment Gross LaboratoryEquipmentGross	3955000	USD
CY2012Q3	exas	Office And Computer Equipment Gross OfficeAndComputerEquipmentGross	825000	USD
CY2012Q3	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	283000	USD
CY2012Q3	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	28000	USD
CY2012Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1462000	USD
CY2012Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1030000	USD
CY2012Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4084000	USD
CY2012Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	4143000	USD
CY2012Q3	exas	Interest Payable Noncurrent InterestPayableNoncurrent	57000	USD
CY2012Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	1331000	USD
CY2012Q3	us-gaap	Common Stock Value CommonStockValue	638000	USD
CY2012Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	370184000	USD
CY2012Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	92000	USD
CY2012Q3	exas	Related Party Transaction Consulting Agreement Term RelatedPartyTransactionConsultingAgreementTerm	P1Y
CY2012Q3	us-gaap	Capital Leases Future Minimum Payments Interest Included In Payments CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments	106000	USD
CY2012Q3	us-gaap	Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments	1151000	USD
CY2012Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-260257000	USD
CY2012Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	39000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	106000	USD
	us-gaap	Depreciation Depreciation	666000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	4024000	USD
	us-gaap	Deferred Revenue Revenue Recognized DeferredRevenueRevenueRecognized	-3108000	USD
	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	152000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	218000	USD
	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	477000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	265000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1483000	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	15000	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	90408000	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	41823000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	586000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	2090000	USD
	us-gaap	Available For Sale Securities Change In Net Unrealized Holding Gain Loss AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLoss	106000	USD
	us-gaap	Deferred Compensation Arrangement With Individual Employer Contribution DeferredCompensationArrangementWithIndividualEmployerContribution	274000	USD
	us-gaap	Stock Issued During Period Value Issued For Noncash Considerations StockIssuedDuringPeriodValueIssuedForNoncashConsiderations	148000	USD
CY2012Q3	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	355000	USD
CY2012Q3	us-gaap	Revenues Revenues	1036000	USD
CY2012Q3	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	796000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	57755000	USD
	us-gaap	Payments To Acquire Equipment On Lease PaymentsToAcquireEquipmentOnLease	1151000	USD
	exas	Capital Leased Assets Lease Term CapitalLeasedAssetsLeaseTerm	P3Y
CY2012Q3	us-gaap	Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation	32000	USD
	exas	Capital Leases Rental Payments Per Month CapitalLeasesRentalPaymentsPerMonth	32000	USD
CY2012Q3	us-gaap	Capital Leases Future Minimum Payments Remainder Of Fiscal Year CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear	127000	USD
CY2012Q3	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	381000	USD
CY2012Q3	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	381000	USD
CY2012Q3	us-gaap	Capital Leases Future Minimum Payments Due In Four Years CapitalLeasesFutureMinimumPaymentsDueInFourYears	368000	USD
CY2012Q3	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	1257000	USD
CY2012Q3	exas	Related Party Transaction Cash Payable Over Consulting Agreement Term RelatedPartyTransactionCashPayableOverConsultingAgreementTerm	60000	USD
CY2012Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P1Y
CY2012Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10491000	USD
CY2012Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2547000	USD
CY2012Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1006000	USD
CY2012Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	67000	USD
CY2012Q3	us-gaap	Interest Expense InterestExpense	11000	USD
CY2012Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.21
CY2012Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	60531000	shares
	us-gaap	Revenues Revenues	3108000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	31692000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7085000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2931000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	188000	USD
	us-gaap	Interest Expense InterestExpense	21000	USD
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.66
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	58104000	shares
	exas	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Under Licensing Agreement ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsUnderLicensingAgreement	250000	shares
	exas	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Under Consulting Agreement ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsUnderConsultingAgreement	75000	shares
	exas	Laboratory Equipment Acquired LaboratoryEquipmentAcquired	1151000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1600000	USD

Files In Submission

Name	View Source	Status
0001104659-12-073727-index-headers.html	Edgar Link	pending
0001104659-12-073727-index.html	Edgar Link	pending
0001104659-12-073727.txt	Edgar Link	pending
0001104659-12-073727-xbrl.zip	Edgar Link	pending
a12-19898_110q.htm	Edgar Link	pending
a12-19898_1ex10d1.htm	Edgar Link	pending
a12-19898_1ex31d1.htm	Edgar Link	pending
a12-19898_1ex31d2.htm	Edgar Link	pending
a12-19898_1ex32d1.htm	Edgar Link	pending
exas-20120930.xml	Edgar Link	completed
exas-20120930.xsd	Edgar Link	pending
exas-20120930_cal.xml	Edgar Link	unprocessable
exas-20120930_def.xml	Edgar Link	unprocessable
exas-20120930_lab.xml	Edgar Link	unprocessable
exas-20120930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
g198981kki001.gif	Edgar Link	pending
g198981kki002.gif	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EXAS
EXACT SCIENCES CORP Stock $exas

2012 Q4 Form 10-Q Financial Statement

#000110465912073727 Filed on November 02, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EXAS EXACT SCIENCES CORP Stock $exas

2012 Q4 Form 10-Q Financial Statement

#000110465912073727 Filed on November 02, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EXAS
EXACT SCIENCES CORP Stock $exas